Qualifying Therapeutic Discovery Project Grants for the State of Montana
The listings below represent the applicants that have been awarded a Qualifying Therapeutic Discovery Program Grant.
The project descriptions below were extracted from the applicant certification forms as submitted.
| Applicant Name | Project Name | Grants Awarded for 2009 | Grants Awarded for 2010 |
|---|---|---|---|
| Ateris Technologies, LLC | Organophosphate poisoning detection and diagnostic systems | $ 244,479.25 | |
| Bacterin International, Inc | Antimicrobial Orthopedic Surgical Fixation Devices | $ 7,500.00 | $ 236,979.25 |
| Genectar Com LLC | New therapy for metastatic melanoma through expanded comparative genomics. | $ 7,836.53 | $ 13,343.30 |
| LigoCyte Pharmaceuticals, Inc | Development of a Vaccine for the Prevention of Human Norovirus Acute Gastroenteritis | $ 244,479.25 | |
| LigoCyte Pharmaceuticals, Inc. | Development of a Novel Virus-like Particle Based Respiratory Syncytial Virus Vaccine | $ 244,479.25 | |
| Microbin Corporation | A Novel, Broad-Spectrum Antimicrobial Therapeutic for Treatment of infectious Diseases | $ 113,575.50 | $ 130,903.75 |
| NanoValent Pharmaceuticals, Inc. | Drug delivery system to treat cancer | $ 9,712.11 | $ 13,500.00 |
| SensoPath Technologies, Inc | Targeted Two-photon Photodynamic Therapy Drugs for Treatment of cancer | $ 13,730.50 | $ 16,452.50 |
References/Related Topics
Page Last Reviewed or Updated: 2012-10-12
